GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » EV-to-FCF

Agilon Health (Agilon Health) EV-to-FCF

: -9.43 (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Agilon Health's Enterprise Value is $1,764 Mil. Agilon Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-187 Mil. Therefore, Agilon Health's EV-to-FCF for today is -9.43.

The historical rank and industry rank for Agilon Health's EV-to-FCF or its related term are showing as below:

AGL' s EV-to-FCF Range Over the Past 10 Years
Min: -224.79   Med: -47.65   Max: -7.79
Current: -9.43

During the past 5 years, the highest EV-to-FCF of Agilon Health was -7.79. The lowest was -224.79. And the median was -47.65.

AGL's EV-to-FCF is ranked worse than
100% of 365 companies
in the Healthcare Providers & Services industry
Industry Median: 20.31 vs AGL: -9.43

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-20), Agilon Health's stock price is $5.46. Agilon Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.640. Therefore, Agilon Health's PE Ratio for today is At Loss.


Agilon Health EV-to-FCF Historical Data

The historical data trend for Agilon Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -60.76 -35.67 -24.92

Agilon Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.67 -45.46 -43.06 -39.69 -24.92

Competitive Comparison

For the Medical Care Facilities subindustry, Agilon Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilon Health EV-to-FCF Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Agilon Health's EV-to-FCF falls into.



Agilon Health EV-to-FCF Calculation

Agilon Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1764.454/-187.014
=-9.43

Agilon Health's current Enterprise Value is $1,764 Mil.
Agilon Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-187 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilon Health  (NYSE:AGL) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Agilon Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.46/-0.640
=At Loss

Agilon Health's share price for today is $5.46.
Agilon Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.640.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Agilon Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Agilon Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilon Health (Agilon Health) Business Description

Traded in Other Exchanges
N/A
Address
6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
Executives
Jeffrey A. Schwaneke director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell director, officer: CEO & President C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker officer: Chief Markets Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia director 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd. 10 percent owner MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai officer: Chief Strategy & Dev. Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer officer: Chief Med. & Quality Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie director METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak officer: Chief Accounting Officer 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias officer: Chief Business Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley officer: Chief Administrative Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723